Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten-H Ohlmann

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Cancer Survivorship : Research and Practice|April 24, 2024
Long-term quality of life of testicular cancer survivors differs according to applied adjuvant treatment and tumour typeJulia Heinzelbecker, Karla Kaßmann, Simone Ernst, et al.
Urologie (Heidelberg, Germany)|March 25, 2026
[Perioperative therapy for muscle-invasive bladder cancer-current treatment concepts]Günter Niegisch, Georgios Gakis, Carsten H Ohlmann, et al.
Molecular Medicine (Cambridge, Mass.)|May 23, 2015
Piwil 2 expression is correlated with disease-specific and progression-free survival of chemotherapy-treated bladder cancer patientsHelge Taubert, Sven Wach, Rudolf Jung, et al.
European Urology|July 16, 2013
Enzalutamide in castration-resistant prostate cancer patients progressing after docetaxel and abirateroneAndres Jan Schrader, Martin Boegemann, Carsten-H Ohlmann, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 12, 2017
CYP17A1-independent production of the neurosteroid-derived 5α-pregnan-3β,6α-diol-20-one in androgen-responsive prostate cancer cell lines under serum starvation and inhibition by AbirateroneAntonio G Gomes de Mello Martins, Giuseppe Allegretta, Gerhard Unteregger, et al.
The Journal of Urology|February 22, 2021
Robotic Salvage Lymph Node Dissection in Recurrent Prostate Cancer: Lessons Learned from 68 Cases and Implications for Future Clinical ManagementJohannes Linxweiler, Jan Sprenk, Katerina Cascetta, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Cancer Survivorship : Research and Practice|April 24, 2024
Long-term quality of life of testicular cancer survivors differs according to applied adjuvant treatment and tumour typeJulia Heinzelbecker, Karla Kaßmann, Simone Ernst, et al.
Urologie (Heidelberg, Germany)|March 25, 2026
[Perioperative therapy for muscle-invasive bladder cancer-current treatment concepts]Günter Niegisch, Georgios Gakis, Carsten H Ohlmann, et al.
Molecular Medicine (Cambridge, Mass.)|May 23, 2015
Piwil 2 expression is correlated with disease-specific and progression-free survival of chemotherapy-treated bladder cancer patientsHelge Taubert, Sven Wach, Rudolf Jung, et al.
European Urology|July 16, 2013
Enzalutamide in castration-resistant prostate cancer patients progressing after docetaxel and abirateroneAndres Jan Schrader, Martin Boegemann, Carsten-H Ohlmann, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 12, 2017
CYP17A1-independent production of the neurosteroid-derived 5α-pregnan-3β,6α-diol-20-one in androgen-responsive prostate cancer cell lines under serum starvation and inhibition by AbirateroneAntonio G Gomes de Mello Martins, Giuseppe Allegretta, Gerhard Unteregger, et al.
The Journal of Urology|February 22, 2021
Robotic Salvage Lymph Node Dissection in Recurrent Prostate Cancer: Lessons Learned from 68 Cases and Implications for Future Clinical ManagementJohannes Linxweiler, Jan Sprenk, Katerina Cascetta, et al.
Pageof 2